✦ LIBER ✦
Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression
✍ Scribed by Gudrun Göhring; Aristoteles Giagounidis; Guntram Büsche; Hans Heinrich Kreipe; Martin Zimmermann; Eva Hellström-Lindberg; Carlo Aul; Brigitte Schlegelberger
- Book ID
- 105989490
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 280 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.